Clinical Trial Update: Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 clinical trial evaluating hepatic arterial infusion of nab-paclitaxel in patients with melanoma with liver met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases
• Melanoma

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Melanoma, Liver Metastasis | Phase 1 | Status: COMPLETED